Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double Umbilical Cord Blood Transplant with RIC in Hematologic Malignancies
NCT00827099Phase 2Terminated
- Sponsor
- Northside Hospital
- Start
- Jun 2006
- Primary completion
- Nov 2009
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood in chronic myeloid leukemia (CML), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML), sponsored by Northside Hospital. Started Jun 2006; status: terminated.
02
Drugs
umbilical cord blood
03
Conditions
chronic myeloid leukemia (CML)acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)myelodysplastic syndrome (MDS)chronic myelomonocytic leukemia (CMML)
Beyond the preview
Go deeper on NCT00827099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827099.